Fresh off first FDA approval, Amicus spends $100M to acquire 10 gene therapies
The company acquired 10 AAV-based gene therapies in development for lysosomal storage disorders, including two already in early clinical trials.
Akouos scores $50M Series A for gene therapy in hearing loss
The Boston-based startup hopes to advance its products into clinical trials in the next 2-3 years, CEO says.
presented by
The Top 6 Best Analytics Tools for Health Care Revenue in 2025
Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources.
MedImmune, 4D Molecular Therapeutics to collaborate on gene therapy
AstraZeneca subsidiary and California-based firm to develop AAV-based therapy for chronic lung disease.